Mark Labow
Novartis (Switzerland)(CH)Novartis (China)(CN)Novartis (United States)(US)
Publications by Year
Research Areas
Cell death mechanisms and regulation, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Phagocytosis and Immune Regulation, Virus-based gene therapy research, RNA Interference and Gene Delivery
Most-Cited Works
- → Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo(2014)724 cited
- → Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex(1995)638 cited
- → Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice(1995)559 cited
- → Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins(1994)380 cited
- → Design of a genome-wide siRNA library using an artificial neural network(2005)377 cited
- → Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells(2003)371 cited